caption
stringlengths 6
2.51k
| molecule
stringlengths 1
747
| properties
sequencelengths 1
86
|
|---|---|---|
The molecule is a emulsifier, nutrient, inflammatory, energy source. The molecule is a surfactant, energy storage, membrane stabilizer, signalling molecule that impacts metabolic syndrome. | CCCCC/C=C\C/C=C\CCCCCCCC(=O)CC(O)COC(C)=O | [
"Emulsifier",
"nutrient",
"inflammatory",
"Energy source",
"surfactant",
"Metabolic syndrome",
"Energy storage",
"Membrane stabilizer",
"signalling molecule"
] |
The molecule is a nutrient. | CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C[C@H]1[C@@H](O)CC(=O)[C@@H]1/C=C/[C@@H](O)CCCCC)COP(=O)(O)OC[C@H](N)C(=O)O | [
"nutrient"
] |
The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, apoptosis that impacts non-alcoholic fatty liver disease and barth syndrome. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts tangier disease, diabetic heart disease, and aging. | CCCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC | [
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Diabetic heart disease",
"Aging"
] |
The molecule is a nutrient and belongs to the thyroxine treatment class of molecules, impacting cardiovascular disease. The molecule is a fat storage that impacts atherosclerosis, pancreatitis, and metabolic syndrome. | CCCC/C=C\CCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)COC(=O)CCCCCCCCCCC/C=C\C/C=C\CCCCC | [
"Cardiovascular disease",
"Thyroxine treatment",
"nutrient",
"Atherosclerosis",
"Pancreatitis",
"Fat storage",
"Metabolic syndrome"
] |
The molecule is a stabilizing mitochondrial structure, a membrane stabilizer, and a proton trap for oxidative phosphorylation, and it impacts aging. The molecule is a apoptosis, a stabilizing cytochrome oxidase, and a surfactant, it impacts non-alcoholic fatty liver disease and is smooth. The molecule is a energy source and a emulsifier, impacting both diabetic heart disease and tangier disease. The molecule is a nutritional supplement, cholesterol translocation, energy storage, food additive that impacts barth syndrome. | CCC(C)CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCC(C)C | [
"Stabilizing mitochondrial structure",
"Aging",
"Membrane stabilizer",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"surfactant",
"Smooth",
"Diabetic heart disease",
"Tangier disease",
"Energy source",
"Emulsifier",
"Nutritional supplement",
"Cholesterol translocation",
"Energy storage",
"food additive",
"Barth syndrome"
] |
The molecule is anti depressant. | CC(=O)n1cc(Nc2ccncc2)c2ccccc21 | [
"anti depressant"
] |
The molecule is a serotonin reuptake inhibitor and tachykinin receptor antagonist, belonging to both the tachykinin antagonist and anti depressant classes of molecules, and is cns disorder treatment. | CC(c1cc(Cl)cc2ccccc12)N(C)C(=O)CC1(c2ccc(F)cc2)CCN(C(=O)OC(C)(C)C)CC1 | [
"cns disorder treatment",
"serotonin reuptake inhibitor",
"tachykinin antagonist",
"tachykinin receptor antagonist",
"anti depressant"
] |
The molecule has Odorless. | N#CCNC(=O)c1cnccc1C(F)(F)F | [
"Odor_evaluation"
] |
The molecule is a nutrient, fat storage, membrane stabilizer that impacts atherosclerosis, cardiovascular disease, and metabolic syndrome. The molecule is a energy storage and energy source, and it impacts obesity. The molecule is a inflammatory and belongs to the thyroxine treatment class of molecules, impacting both cancer and pancreatitis. | CCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Atherosclerosis",
"nutrient",
"Cardiovascular disease",
"Fat storage",
"Metabolic syndrome",
"Membrane stabilizer",
"Obesity",
"Energy storage",
"Energy source",
"Thyroxine treatment",
"Cancer",
"Pancreatitis",
"inflammatory"
] |
It belongs to the anti bacterial, anti tumor, and anti tumour classes of molecules. | CC(C)(C)c1ccccc1Nc1c(C(=O)O)cccc1C(=O)O | [
"anti bacterial",
"anti tumor",
"anti tumour"
] |
The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure that impacts aging, tangier disease, and barth syndrome. The molecule is a apoptosis, cholesterol translocation, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease and diabetic heart disease. | CCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC | [
"Aging",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease"
] |
It belongs to the hypertension treatment class of molecules. | CCCCc1cnc(C(=O)N(C)C)c(Cl)c1Cl | [
"hypertension treatment"
] |
The molecule is a apoptosis, cholesterol translocation, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts barth syndrome. The molecule is a stabilizing cytochrome oxidase that impacts diabetic heart disease, aging, non-alcoholic fatty liver disease, and tangier disease. | CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCC(C)C | [
"Apoptosis",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Aging",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Stabilizing cytochrome oxidase"
] |
The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, barth syndrome, and diabetic heart disease. The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, apoptosis that impacts aging and tangier disease. | CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCC | [
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Aging",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Tangier disease"
] |
The molecule is both a pi3k inhibitor and a cancer treatment. | Cc1nc2c(C(=O)O)cc(N3CCOCC3)c(F)c2n1-c1ccnc2c(Cl)ccc(F)c12 | [
"pi3k inhibitor",
"cancer treatment"
] |
The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts aging and non-alcoholic fatty liver disease. The molecule is a apoptosis and a cholesterol translocation that impacts barth syndrome, diabetic heart disease, and tangier disease. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\CCCCCC | [
"Aging",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Apoptosis",
"Cholesterol translocation",
"Diabetic heart disease",
"Tangier disease"
] |
It impacts insulin resistance. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC/C=C\CCCCCC | [
"Insulin resistance"
] |
The molecule is thyroxine treatment and it impacts both atherosclerosis and cardiovascular disease. The molecule is a fat storage and a nutrient, impacting both pancreatitis and metabolic syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCCCCCCCCC | [
"Atherosclerosis",
"Thyroxine treatment",
"Cardiovascular disease",
"Fat storage",
"nutrient",
"Pancreatitis",
"Metabolic syndrome"
] |
The molecule is a membrane stabilizer, energy source, and thyroxine treatment that has an effect on cancer and impacts both metabolic syndrome and atherosclerosis. The molecule is a fat storage and nutrient, and it impacts obesity. The molecule is a energy storage and a inflammatory, impacting both cardiovascular disease and pancreatitis. | CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCC(C)CC | [
"Metabolic syndrome",
"Membrane stabilizer",
"Energy source",
"Thyroxine treatment",
"Atherosclerosis",
"Cancer",
"Fat storage",
"nutrient",
"Obesity",
"Energy storage",
"Cardiovascular disease",
"Pancreatitis",
"inflammatory"
] |
It belongs to the anti microbial class of molecules. | CC(N)CCCN1CCCC1c1cc2cn(-c3ccc(C4CCCC(CCSC(=N)N)N4)cc3)c(=O)nc2[nH]1 | [
"anti microbial"
] |
The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts barth syndrome, non-alcoholic fatty liver disease, and tangier disease. The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, apoptosis that impacts diabetic heart disease and aging. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Cholesterol translocation",
"Apoptosis",
"Aging"
] |
The molecule is a membrane stabilizer, surfactant, energy storage, emulsifier, energy source, nutrient. | CC(CCC=C(CO)CO)C1CC(O)C2(C)C3=CCC4C(C)(C)C(=O)CCC4(C)C3=CCC12C | [
"Membrane stabilizer",
"surfactant",
"Energy storage",
"Emulsifier",
"Energy source",
"nutrient"
] |
The molecule is a anti viral. | CC1NC(=O)C(C(C)C)OC(=O)C(C)(C)C=Cc2ccc3ccc(nc3c2)CNC(=O)C2CCCN(N2)C1=O | [
"anti viral"
] |
The molecule is a anti microbial member of the anti bacterial class. | COc1ccccc1N1CCN(C(=O)c2ccccc2C(=O)O)CC1 | [
"anti microbial",
"anti bacterial"
] |
The molecule is a nutrient that affects both cervical cancer and breast cancer, and also impacts ulcerative colitis and atherosclerosis. | CC/C=C\C/C=C\C/C=C\C/C=C\C=C/C(O)C/C=C\CCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Cervical cancer",
"Ulcerative colitis",
"nutrient",
"Breast cancer",
"Atherosclerosis"
] |
The molecule is a apoptosis, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts aging, diabetic heart disease, and tangier disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O[C@H](COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCC | [
"Apoptosis",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Aging",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Cholesterol translocation"
] |
The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts tangier disease, non-alcoholic fatty liver disease, and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, stabilizing mitochondrial structure that impacts aging and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC | [
"Tangier disease",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Aging",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Stabilizing mitochondrial structure"
] |
The molecule is a kinase inhibitor. | O=C(Nc1cccc(C(F)(F)F)c1)Nc1cccc2c1ccn2Cc1ccnc2[nH]ccc12 | [
"kinase inhibitor"
] |
The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, stabilizing mitochondrial structure that impacts aging and barth syndrome. The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, tangier disease, and diabetic heart disease. | CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCC | [
"Stabilizing cytochrome oxidase",
"Aging",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts tangier disease, aging, and barth syndrome. | CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C | [
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Tangier disease",
"Aging",
"Barth syndrome",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing cytochrome oxidase, cholesterol translocation that impacts aging. The molecule is a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, diabetic heart disease, tangier disease, and barth syndrome. | CCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCC(C)C)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C | [
"Aging",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Tangier disease",
"Barth syndrome",
"Stabilizing mitochondrial structure"
] |
The molecule is a nutritional supplement and a proton trap for oxidative phosphorylation, impacting both barth syndrome and tangier disease. The molecule is a apoptosis, stabilizing mitochondrial structure, energy storage, membrane stabilizer, and smooth. The molecule is a surfactant, a cholesterol translocation, and a food additive, and it impacts diabetic heart disease. The molecule is a energy source, stabilizing cytochrome oxidase, emulsifier that impacts non-alcoholic fatty liver disease and aging. | CCC(C)CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C | [
"Nutritional supplement",
"Proton trap for oxidative phosphorylation",
"Barth syndrome",
"Tangier disease",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Energy storage",
"Smooth",
"Membrane stabilizer",
"surfactant",
"Diabetic heart disease",
"Cholesterol translocation",
"food additive",
"Energy source",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Emulsifier",
"Aging"
] |
The molecule is a energy storage that impacts diabetes mellitus, breast cancer, and stomach cancer. The emulsifier molecule affects colorectal cancer, impacts alzheimer's disease, and is smooth. The molecule is a energy source, a nutritional supplement, and a membrane stabilizer, and it impacts seizure. The molecule is a signalling molecule, surfactant, food additive that impacts cardiovascular disease and parkinson's disease. | CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)O[C@H]1C(O)C(O)C(O)[C@@H](O)C1O)OC(=O)CCCCCCCCCCCCCCC | [
"Diabetes mellitus",
"Breast cancer",
"Stomach cancer",
"Energy storage",
"Colorectal cancer",
"Alzheimer's Disease",
"Smooth",
"Emulsifier",
"Energy source",
"Seizure",
"Nutritional supplement",
"Membrane stabilizer",
"signalling molecule",
"Cardiovascular disease",
"Parkinson's disease",
"surfactant",
"food additive"
] |
It impacts insulin resistance, neurodegenerative disease, and diabetes mellitus. | CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCCCCCCCCCCCCCC | [
"Insulin resistance",
"Neurodegenerative disease",
"Diabetes mellitus"
] |
The molecule is a hcv inhibitor. | COC(C)CC=CC(C)(C)C | [
"hcv inhibitor"
] |
The molecule is a thrombin inhibitor, nmda antagonist, factor xa inhibitor, anti coagulant and belongs to the allergic disease treatment class of molecules. | CC(C)(C)OC(=O)n1c(Cl)cc2ccccc21 | [
"thrombin inhibitor",
"nmda antagonist",
"allergic disease treatment",
"factor xa inhibitor",
"anti coagulant"
] |
The molecule is both a erk inhibitor and a hcv protease inhibitor. | C#Cc1cccc(C(C)(CC)CCC)n1 | [
"erk inhibitor",
"hcv protease inhibitor"
] |
The molecule is a anti viral activity and a hepatitis c treatment, belonging to the anti viral class of molecules. | CCCc1cc2oc(-c3ccc(F)cc3)c(C=O)c2cc1-c1ccc(F)c(C)c1 | [
"anti viral activity",
"hepatitis c treatment",
"anti viral"
] |
The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, apoptosis that impacts non-alcoholic fatty liver disease and aging. The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts diabetic heart disease, barth syndrome, and tangier disease. | CCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCCCC(C)C | [
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation",
"Aging",
"Apoptosis",
"Diabetic heart disease",
"Barth syndrome",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Tangier disease"
] |
The molecule is a surfactant, a emulsifier, a membrane stabilizer, and smooth. The molecule is a nutritional supplement, energy storage, apoptosis that impacts diabetic heart disease and tangier disease. The molecule is a cholesterol translocation and a energy source, impacting both barth syndrome and aging. The molecule is a food additive, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease. | CC(C)CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCC(C)C | [
"Smooth",
"surfactant",
"Emulsifier",
"Membrane stabilizer",
"Diabetic heart disease",
"Nutritional supplement",
"Tangier disease",
"Energy storage",
"Apoptosis",
"Cholesterol translocation",
"Barth syndrome",
"Energy source",
"Aging",
"food additive",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase"
] |
The molecule is a nutrient that impacts non-alcoholic fatty liver disease, diabetes mellitus type 2, alzheimer's disease, and parkinson's disease. | CCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCC[C@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCCCC)COP(=O)(O)OCCN | [
"Non-alcoholic fatty liver disease",
"Diabetes mellitus type 2",
"Alzheimer's Disease",
"Parkinson's disease",
"nutrient"
] |
The molecule is a nutritional supplement, a food additive, and a proton trap for oxidative phosphorylation, and it impacts diabetic heart disease. The molecule is a emulsifier, membrane stabilizer, stabilizing mitochondrial structure, energy source, and smooth. The molecule is a stabilizing cytochrome oxidase, a surfactant, and a energy storage, and it impacts aging. The molecule is a apoptosis and a cholesterol translocation that impacts non-alcoholic fatty liver disease, tangier disease, and barth syndrome. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\C=C/CCCCCC | [
"Nutritional supplement",
"food additive",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Emulsifier",
"Membrane stabilizer",
"Smooth",
"Stabilizing mitochondrial structure",
"Energy source",
"Stabilizing cytochrome oxidase",
"Aging",
"surfactant",
"Energy storage",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Tangier disease",
"Barth syndrome",
"Cholesterol translocation"
] |
The molecule is a energy storage, fat storage, energy source that impacts metabolic syndrome, atherosclerosis, and obesity. The molecule is a inflammatory and thyroxine treatment, and it impacts pancreatitis. The molecule is a nutrient and a membrane stabilizer, with effects on cancer and impacts on cardiovascular disease. | CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Metabolic syndrome",
"Atherosclerosis",
"Energy storage",
"Obesity",
"Fat storage",
"Energy source",
"Pancreatitis",
"inflammatory",
"Thyroxine treatment",
"Cardiovascular disease",
"nutrient",
"Membrane stabilizer",
"Cancer"
] |
The molecule is a apoptosis, cholesterol translocation, stabilizing mitochondrial structure that impacts diabetic heart disease and barth syndrome. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation that impacts tangier disease, non-alcoholic fatty liver disease, and aging. | CCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC | [
"Apoptosis",
"Cholesterol translocation",
"Diabetic heart disease",
"Barth syndrome",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Aging",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a flavoring agent that is nutty and earthy. The molecule is raw, potato, roasted, and strong. | Cc1cc(C)c(C)o1 | [
"Flavoring agent",
"nutty",
"earthy",
"raw",
"potato",
"roasted",
"strong"
] |
The molecule is a cholesterol translocation, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts diabetic heart disease. The molecule is a apoptosis that impacts aging, barth syndrome, non-alcoholic fatty liver disease, and tangier disease. | CC/C=C\C/C=C\C/C=C\CCCCCCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC | [
"Diabetic heart disease",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Aging",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Tangier disease"
] |
The molecule is a anti asthmatic member of the anti epileptic class. | CNC(=S)C1=CC(COC)(COC)Oc2ccc([N+](=O)[O-])cc21 | [
"anti epileptic",
"anti asthmatic"
] |
The molecule is a kinase inhibitor. | CC1CC(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)ccc(O)c3F)n2)CC(N)C1O | [
"kinase inhibitor"
] |
The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing mitochondrial structure that impacts tangier disease and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts aging, non-alcoholic fatty liver disease, and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC | [
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Aging",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Barth syndrome"
] |
The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts diabetic heart disease, non-alcoholic fatty liver disease, and tangier disease. The molecule is a stabilizing cytochrome oxidase, apoptosis, cholesterol translocation that impacts aging and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCC | [
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Aging",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Barth syndrome",
"Cholesterol translocation"
] |
The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, cholesterol translocation that impacts diabetic heart disease. The molecule is a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, tangier disease, barth syndrome, and aging. | CCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCC(C)C)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C | [
"Apoptosis",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Barth syndrome",
"Stabilizing mitochondrial structure",
"Aging"
] |
The molecule is a energy storage, fat storage, nutrient, energy source that impacts cardiovascular disease and obesity. The molecule is a thyroxine treatment and membrane stabilizer with an effect on cancer. The molecule is a inflammatory that impacts metabolic syndrome, pancreatitis, and atherosclerosis. | CCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Energy storage",
"Fat storage",
"nutrient",
"Energy source",
"Cardiovascular disease",
"Obesity",
"Thyroxine treatment",
"Membrane stabilizer",
"Cancer",
"Metabolic syndrome",
"Pancreatitis",
"inflammatory",
"Atherosclerosis"
] |
The molecule is anti bacterial. | COc1c(N2CCC(C(C)N)C2)c(F)c(N)c2c(=O)c(C(=O)O)cn(C3CC3)c12 | [
"anti bacterial"
] |
The molecule is anti tumor. | CCCCCCCCCCCCCCC(C#N)C(=O)N(c1ccnc(=O)[nH]1)C1OC2CO[Si](C(C)C)(C(C)C)O[Si](C(C)C)(C(C)C)OC2C1(O)OC(=S)Oc1ccccc1 | [
"anti tumor"
] |
The molecule is a stabilizing cytochrome oxidase, apoptosis, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and aging. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts barth syndrome, tangier disease, and diabetic heart disease. | CCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC | [
"Non-alcoholic fatty liver disease",
"Aging",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Diabetic heart disease"
] |
The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts non-alcoholic fatty liver disease, aging, and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation, cholesterol translocation, stabilizing mitochondrial structure that impacts barth syndrome and tangier disease. | CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCCCCCC | [
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Aging",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Barth syndrome",
"Tangier disease",
"Stabilizing mitochondrial structure"
] |
The molecule is a nutrient that affects cervical cancer by impacting atherosclerosis, ulcerative colitis, and breast cancer. | CCCCC/C=C\C/C=C\C/C=C\CC1OC1CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C | [
"Atherosclerosis",
"Ulcerative colitis",
"nutrient",
"Breast cancer",
"Cervical cancer"
] |
The molecule is a fat storage and nutrient, and it impacts cardiovascular disease. The molecule is a member of the thyroxine treatment class and affects atherosclerosis, metabolic syndrome, and pancreatitis. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCC/C=C\C/C=C\CCCCC | [
"Fat storage",
"nutrient",
"Cardiovascular disease",
"Atherosclerosis",
"Thyroxine treatment",
"Metabolic syndrome",
"Pancreatitis"
] |
The molecule is a angiogenesis inhibitor and a protein tyrosine kinase inhibitor, belonging to the neurodegenerative disease treatment class of molecules, impacts psychiatric treatment, and is neurological treatment. | COc1cc(OC)cc(C2OCCO2)c1 | [
"neurodegenerative disease treatment",
"psychiatric treatment",
"neurological treatment",
"angiogenesis inhibitor",
"protein tyrosine kinase inhibitor"
] |
The molecule is a organic light-emitting device and belongs to the electronic device class of molecules. | N#Cc1cccc(C#N)c1-c1cc(-c2ccccc2)cc2c1c1ccccc1n2-c1ccccc1 | [
"electronic device",
"organic light-emitting device"
] |
The molecule is a fat storage, energy source, energy storage that impacts atherosclerosis, cancer, and obesity. The molecule is a nutrient that impacts both cardiovascular disease and pancreatitis. The molecule is a thyroxine treatment, a inflammatory, and a membrane stabilizer, and it impacts metabolic syndrome. | CCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCC | [
"Atherosclerosis",
"Cancer",
"Obesity",
"Fat storage",
"Energy source",
"Energy storage",
"Cardiovascular disease",
"nutrient",
"Pancreatitis",
"Thyroxine treatment",
"inflammatory",
"Metabolic syndrome",
"Membrane stabilizer"
] |
The molecule is a membrane stabilizer, fat storage, nutrient, inflammatory that impacts cardiovascular disease and pancreatitis. The molecule is a energy source and energy storage, and it impacts obesity. The molecule is thyroxine treatment and impacts atherosclerosis, cancer, and metabolic syndrome. | CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C | [
"Membrane stabilizer",
"Fat storage",
"nutrient",
"inflammatory",
"Cardiovascular disease",
"Pancreatitis",
"Energy source",
"Obesity",
"Energy storage",
"Thyroxine treatment",
"Atherosclerosis",
"Cancer",
"Metabolic syndrome"
] |
The molecule is a member of the organic electroluminescent material, luminescent, and electroluminescent classes and has an effect on organic electroluminescence, while being light-emitting. | CC(C)(C)c1cc(N(c2ccccc2)c2cccc3c2oc2c(C4CCCC4)cccc23)c2ccc3c(C(C)(C)C)cc(N(c4ccccc4)c4cccc5c4oc4c(C6CCCC6)cccc45)c4ccc1c2c43 | [
"organic electroluminescent material",
"organic electroluminescence",
"luminescent",
"light-emitting",
"electroluminescent"
] |
The molecule is both a anti inflammatory and a serine protease inhibitor. | COc1cc2nc(OCc3ccccc3)oc(=O)c2cc1OC | [
"anti inflammatory",
"serine protease inhibitor"
] |
The molecule is a prostaglandin inhibitor and belongs to the anti inflammatory class of molecules. | CCc1cc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)c(F)c2)ccc1-c1cscn1 | [
"anti inflammatory",
"prostaglandin inhibitor"
] |
The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, tangier disease, and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, cholesterol translocation that impacts barth syndrome and aging. | CCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCC(C)C | [
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Barth syndrome",
"Aging"
] |
The molecule has Odorless. When heated to decomposition it emits toxic fumes of nitrogen oxides. | N=c1nc(N2CCCCC2)cc(N)n1O | [
"Odor_evaluation",
"Decomposition_evaluation"
] |
The molecule is a factor xa inhibitor and fxa inhibitor, belonging to both the anti coagulant and cardiovascular disease treatment classes of molecules. | CN(Cc1ccccc1)C(=O)CN1CCCC(NS(=O)(=O)c2cc3ccc(Cl)cc3s2)C1=O | [
"factor xa inhibitor",
"anti coagulant",
"cardiovascular disease treatment",
"fxa inhibitor"
] |
The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts barth syndrome, non-alcoholic fatty liver disease, and aging. The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts diabetic heart disease and tangier disease. | CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC(C)CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCC | [
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Aging",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Tangier disease",
"Stabilizing mitochondrial structure"
] |
The molecule is a energy source, nutrient, energy storage, fat storage that has an effect on cancer and impacts pancreatitis. The molecule is a member of the thyroxine treatment class and affects both obesity and metabolic syndrome. The molecule is a membrane stabilizer and a inflammatory, impacting both atherosclerosis and cardiovascular disease. | CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCC | [
"Energy source",
"nutrient",
"Energy storage",
"Cancer",
"Pancreatitis",
"Fat storage",
"Thyroxine treatment",
"Obesity",
"Metabolic syndrome",
"Atherosclerosis",
"Membrane stabilizer",
"inflammatory",
"Cardiovascular disease"
] |
The molecule has Odorless. | CN=C(NCC1CCOC1)N[N+](=O)[O-] | [
"Odor_evaluation"
] |
The molecule is a protease inhibitor and is hiv treatment. | COC(=O)CCC(=O)NC(Cc1ccccc1)C(O)CC(NC(=O)c1cccc(Oc2ccccc2)c1)C1CCCCC1 | [
"protease inhibitor",
"hiv treatment"
] |
The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts aging and barth syndrome. The molecule is a apoptosis and a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, diabetic heart disease, and tangier disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC | [
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Aging",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Tangier disease"
] |
The molecule is a inflammatory, energy source, energy storage, fat storage, membrane stabilizer, nutrient. It impacts metabolic syndrome, pancreatitis, and obesity. It is a member of the thyroxine treatment class of molecules that affects cancer and has an impact on both cardiovascular disease and atherosclerosis. | CC(C)CCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C | [
"inflammatory",
"Energy source",
"Energy storage",
"Fat storage",
"Membrane stabilizer",
"nutrient",
"Metabolic syndrome",
"Pancreatitis",
"Obesity",
"Cancer",
"Thyroxine treatment",
"Cardiovascular disease",
"Atherosclerosis"
] |
The molecule is a fat storage that impacts obesity, cancer, thyroxine treatment, atherosclerosis, and pancreatitis. The molecule is a energy storage and nutrient, and it impacts metabolic syndrome. The molecule is a membrane stabilizer, a energy source, and a inflammatory, and it impacts cardiovascular disease. | CCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Obesity",
"Cancer",
"Fat storage",
"Thyroxine treatment",
"Atherosclerosis",
"Pancreatitis",
"Energy storage",
"nutrient",
"Metabolic syndrome",
"Membrane stabilizer",
"Energy source",
"Cardiovascular disease",
"inflammatory"
] |
The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis that impacts non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts aging, barth syndrome, and tangier disease. | CCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC(C)C | [
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Cholesterol translocation",
"Aging",
"Barth syndrome",
"Stabilizing mitochondrial structure",
"Tangier disease"
] |
The molecule is a nutrient that impacts diabetes mellitus type 2, parkinson's disease, alzheimer's disease, and non-alcoholic fatty liver disease. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCC/C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]1O | [
"nutrient",
"Diabetes mellitus type 2",
"Parkinson's disease",
"Alzheimer's Disease",
"Non-alcoholic fatty liver disease"
] |
The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts aging, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a apoptosis, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts diabetic heart disease and tangier disease. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC | [
"Aging",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Diabetic heart disease",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Tangier disease"
] |
The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts tangier disease, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts aging and diabetic heart disease. | CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C | [
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Cholesterol translocation",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Aging",
"Diabetic heart disease"
] |
The molecule is a thyroxine treatment, a fat storage, and a nutrient. It impacts metabolic syndrome, cardiovascular disease, pancreatitis, and atherosclerosis. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\CCCCCCCC | [
"Thyroxine treatment",
"Fat storage",
"nutrient",
"Metabolic syndrome",
"Cardiovascular disease",
"Pancreatitis",
"Atherosclerosis"
] |
The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, cholesterol translocation that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts diabetic heart disease, aging, and tangier disease. | CCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC)OC(=O)CCCCCCCCCCC(C)C | [
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Aging",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Apoptosis"
] |
The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts non-alcoholic fatty liver disease, tangier disease, and aging. The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, proton trap for oxidative phosphorylation that impacts barth syndrome and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Apoptosis",
"Aging",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease"
] |
The molecule is a schizophrenia treatment. | CC(C)(C)OC(=O)NCC(C)(C)c1cccc(Br)c1N | [
"schizophrenia treatment"
] |
The molecule is a cholesterol translocation, apoptosis, proton trap for oxidative phosphorylation that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase that impacts diabetic heart disease, aging, and tangier disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC | [
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Aging",
"Tangier disease",
"Stabilizing cytochrome oxidase"
] |
The molecule is a energy storage, inflammatory, energy source that impacts obesity, metabolic syndrome, and pancreatitis. The molecule is a nutrient that impacts both cardiovascular disease and cancer. The molecule is a membrane stabilizer and a fat storage, it impacts atherosclerosis, and is thyroxine treatment. | CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC(C)C | [
"Energy storage",
"inflammatory",
"Obesity",
"Metabolic syndrome",
"Energy source",
"Pancreatitis",
"Cardiovascular disease",
"nutrient",
"Cancer",
"Thyroxine treatment",
"Membrane stabilizer",
"Fat storage",
"Atherosclerosis"
] |
The molecule is a hiv integrase inhibitor, a aids treatment, and anti viral. | N#Cc1ccc(F)cc1N1CCOCS1(=O)=O | [
"anti viral",
"hiv integrase inhibitor",
"AIDs treatment"
] |
It belongs to the anti biotic class of molecules. | CC(C)(ON=C(C(=O)NC1C(=O)N2C(C(=O)O)=C(CSc3ncncc3-c3ccc(O)c(O)c3)CSC12)c1csc(N)n1)C(=O)NO | [
"anti biotic"
] |
The molecule is a apoptosis, proton trap for oxidative phosphorylation, cholesterol translocation that impacts tangier disease and barth syndrome. The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure that impacts diabetic heart disease, aging, and non-alcoholic fatty liver disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCCCC | [
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Cholesterol translocation",
"Barth syndrome",
"Diabetic heart disease",
"Aging",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure"
] |
The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts aging, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, apoptosis that impacts tangier disease and diabetic heart disease. | CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCC(C)C | [
"Aging",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Diabetic heart disease",
"Apoptosis"
] |
The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a apoptosis and a cholesterol translocation that impacts tangier disease, aging, and diabetic heart disease. | CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCCCC(C)C | [
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Aging",
"Apoptosis",
"Cholesterol translocation",
"Diabetic heart disease"
] |
The molecule is a nutrient, green, licorice, petroleum, vegetable skin. The molecule is a flavoring agent, waxy, rue, fresh, clean. | CC(=O)/C=C/C1CCC1(C)C | [
"green",
"licorice",
"petroleum",
"vegetable skin",
"nutrient",
"waxy",
"rue",
"fresh",
"clean",
"Flavoring agent"
] |
The molecule is a proton trap for oxidative phosphorylation and a apoptosis that impacts tangier disease, diabetic heart disease, and barth syndrome. The molecule is a stabilizing mitochondrial structure, cholesterol translocation, stabilizing cytochrome oxidase that impacts aging and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Tangier disease",
"Diabetic heart disease",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Aging",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase"
] |
The molecule is a energy source, membrane stabilizer, and inflammatory that has an effect on cancer and impacts both metabolic syndrome and cardiovascular disease. The molecule is a nutrient and thyroxine treatment, and it impacts atherosclerosis. The molecule is a energy storage and a fat storage, impacting both pancreatitis and obesity. | CCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCC | [
"Energy source",
"Membrane stabilizer",
"Metabolic syndrome",
"Cardiovascular disease",
"Cancer",
"inflammatory",
"Atherosclerosis",
"Thyroxine treatment",
"nutrient",
"Pancreatitis",
"Obesity",
"Energy storage",
"Fat storage"
] |
The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts aging, non-alcoholic fatty liver disease, and diabetic heart disease. The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts tangier disease and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC)COP(=O)(O)OCC(O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Aging",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Barth syndrome"
] |
The molecule is a dgat inhibitor and belongs to the obesity treatment class of molecules. | CCOc1cc(OCC)cc(C(=O)Nc2ccc(-c3ccc4c(c3)C(=O)N(C(C(=O)O)C(C)C)C4)cc2)c1 | [
"dgat inhibitor",
"obesity treatment"
] |
The molecule is a platelet aggregation inhibitor. | CCC(CC)n1c(=O)n(CC=CC(=O)O)c(=O)c2cc(F)c(NCC3CC3)cc21 | [
"platelet aggregation inhibitor"
] |
The molecule is a nutrient that affects cervical cancer by impacting atherosclerosis, ulcerative colitis, and breast cancer. | CC/C=C/C/C=C/C=C/C(O)CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCC | [
"nutrient",
"Atherosclerosis",
"Cervical cancer",
"Ulcerative colitis",
"Breast cancer"
] |
The molecule is a protein kinase inhibitor that impacts cancer treatment. | COC1CCN(C2CN(C)C2)CC1 | [
"protein kinase inhibitor",
"cancer treatment"
] |
The molecule is a immunomodulator that is anti viral agent and anti viral. | CCCC(C)(CO)NC(CO)c1ccccc1 | [
"anti viral agent",
"anti viral",
"immunomodulator"
] |
The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts aging, barth syndrome, and tangier disease. | CCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC)OC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C | [
"Apoptosis",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Aging",
"Barth syndrome",
"Tangier disease",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase"
] |